Patents by Inventor Niki Gunkel

Niki Gunkel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic double-stranded oligonucleotides for specific inhibition of gene expression
    Patent number: 8772469
    Abstract: The present invention relates to oligonucleotide derivatives which are at least partly double-stranded and which have a 2?5?-linked oligonucleotide residue on at least one 3? end and to the use thereof for specific inhibition of gene expression.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: July 8, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Eugen Uhlmann, Jochen Huber, Niki Gunkel, Sandra Neumann
  • Oligoribonucleotide derivatives for specific inhibition of gene expression
    Patent number: 7635769
    Abstract: The present invention relates to oligoribonucleotide derivatives which have a 2?5?-linked oligoribonucleotide residue without a 5?-phosphate residue on the 3? end and to the use thereof for specific inhibition of gene expression.
    Type: Grant
    Filed: September 22, 2005
    Date of Patent: December 22, 2009
    Assignee: Sanofi-Aventis Drutschland
    Inventors: Eugen Uhlmann, Jochen Huber, Niki Gunkel, Sandra Neumann
  • Novel oligoribonucleotide derivatives for specific inhibition of gene expression
    Publication number: 20060025374
    Abstract: The present invention relates to oligoribonucleotide derivatives which have a 2?5?-linked oligoribonucleotide residue without a 5?-phosphate residue on the 3? end and to the use thereof for specific inhibition of gene expression.
    Type: Application
    Filed: September 22, 2005
    Publication date: February 2, 2006
    Inventors: Eugen Uhlmann, Jochen Huber, Niki Gunkel, Sandra Neumann
  • Synthetic double-stranded oligonucleotides for specific inhibition of gene expression
    Publication number: 20030139585
    Abstract: The present invention relates to oligonucleotide derivatives which are at least partly double-stranded and which have a 2′5′-linked oligonucleotide residue on at least one 3′ end and to the use thereof for specific inhibition of gene expression.
    Type: Application
    Filed: July 11, 2002
    Publication date: July 24, 2003
    Inventors: Eugen Uhlmann, Jochen Huber, Niki Gunkel, Sandra Neumann
  • Oligoribonucleotide derivatives for specific inhibition of gene expression
    Publication number: 20030105052
    Abstract: The present invention relates to oligoribonucleotide derivatives which have a 2′5′-linked oligoribonucleotide residue without a 5′-phosphate residue on the 3′ end and to the use thereof for specific inhibition of gene expression.
    Type: Application
    Filed: July 11, 2002
    Publication date: June 5, 2003
    Inventors: Eugen Uhlmann, Jochen Huber, Niki Gunkel, Sandra Neumann